Finn Partners welcomes the latest addition to its global healthcare practice with the appoint of Geralyn LaNeve as Group Vice President.
Finn Partners has appointed Geralyn LaNeve as Group Vice President for the agency’s global health practice. She will be based in New York, and report to Michael Heinley, Partner and Deputy of the New York health group.
LaNeve was previously Senior Vice President at Alembic Unlimited, a sister company of Cooney Waters Unlimited, where she supervised communications and advocacy initiatives in the infectious disease and vaccines, oncology, and rare disease categories.
Her background also includes communications roles at The Leukemia & Lymphoma Society and New York Organ Donor Network where her work focused on strengthening the visibility and reputation of the mission-driven brands, while increasing awareness of critical health issues.
She developed partnerships between clients and stakeholders to include industry, government, policy makers as well as professional and patient groups. Before Alembic, she was VP at Ruder Finn Healthcare where she managed U.S. and global communications for pharmaceuticals brands.
“Our clients will benefit from her experience in managing advocacy relations programs and providing strategic leadership in public health on behalf of both for-profit and non-profit groups,” said Kristie Kuhl, Senior Partner at Finn Partners Health Practice.
